Data from Phase 3b ENSURE-AF Study Investigating Once-Daily LIXIANA® (edoxaban)in Patients with Atrial Fibrillation Undergoing Cardioversion Among 13 Daiichi Sankyo Clinical Presentations at ESC Congress 2016 - Seite 2

and Thromboembolic
Risk in Bio-Medico, Rome, Location:

Patients with Atrial Italy
Poster Area
Fibrillation: A PREFER in AF

Registry Sub-study

Antithrombotic Management of
Giulia Renda, MD, PhD Sunday, August 28,
Atrial
Fibrillation: Follow-up G. d'Annunzio University 2:00-6:00
PM CET
Data from the PREFER in AF of Chieti-Pescara
Location:
Registry Chieti,
Italy Poster Area

The HAS-BLED Score for
Prediction Miklos Rohla, MD, Sunday, August 28,
of
Stroke and Systemic Embolism: Medical University of
2:00-6:00 PM CET
Insights from the PREvention oF Vienna,
Vienna, Austria Location:
thromboembolic events - European
Poster Area
Registry in Atrial
Fibrillation
(PREFER in AF)

Patients' Convenience and
Raffaele De Caterina, MD, Sunday, August 28,
Satisfaction
as Important Factors PhD, FESC, G. d'Annunzio 2:00-6:00 PM
CET
Related to Switching from Vitamin University of Chieti-
Location:
K Antagonists to NOACs - A PREFER Pescara
Chieti, Italy Poster Area
in AF Registry
Analysis


Moderated Poster Presentation

Hospitalization-Related Costs Elizabeth A. Magnuson, ScD,
Tuesday, August 30,
Among Patients with Atrial Saint
Lukes Hospital, 10:25-10:35 AM CET
Fibrillation Treated
with the Kansas City, Missouri, Location: Moderated

Factor Xa Inhibitor Edoxaban vs United States of America
Poster Station -
Warfarin: Results from the ENGAGE
Poster Area
AF-TIMI 48 Trial

Rapid Fire Abstracts
Linking Intrinsic Factor X
Ophelia Q. Yin, Phd, FCP, Sunday, August 28,
Activity, a
Biologically Relevant Daiichi Sankyo, Edison, 11:36-11:45
AM CET
Pharmacodynamic Marker, to New Jersey, United
Location: Agora 1 -
Edoxaban Plasma Concentration and
States of America Poster Area
Clinical Outcomes in
the ENGAGE
AF-TIMI 48 Trial

Gender Differences in Clinical
Renate B. Schnabel, MD, Monday, August 29,

Presentation and Predictors of MSc University Heart Center
9:15-9:24 AM CET
One-Year Outcomes in Atrial Hamburg,
Hamburg, Germany Location: Agora 1 -
Fibrillation
Poster Area


Relationship Between Body Mass Giuseppe Boriani, MD, PhD,
Tuesday, August 30,
Index and Outcomes in 21,028
University of Modena, 2:09-2:18 PM CET
Patients with
Atrial Fibrillation Modena, Italy Location: Agora
2 -
Treated with Edoxaban or Warfarin
Poster Area
in ENGAGE AF-TIMI 48 Trial

Management of
Acute Venous Rupert Bauersachs, MD, Tuesday, August
30,
Thromboembolism in Europe - Max Ratschow Clinic for
5:06-5:15 PM CET
Follow-up Data at
1 Month from Angiology, Darmstadt, Location: Galileo -

the PREFER in VTE Registry Germany
The Hub

Young Investigator Awards